The variant rs266729 has been reported to be associated with higher circulating adiponectin levels [31,32], higher plasma total antioxidant status (32), lower plasma oxidized-LDL levels [33], and reduced risk for type 2 diabetes [34]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.